We are live on ! Find out more

Micro Cap Biotechnology
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
TTRX
1
Turn Therapeutics
TTRX
$249M
$249M $8.36 1.33%
VRXA
2
Veraxa Biotech AG
VRXA
$249M
$249M $1.76 10.2%
ADAG
3
Adagene
ADAG
$248M
$248M $3.75 0.54%
PRQR icon
4
ProQR Therapeutics
PRQR
$243M
$243M $1.72 3.37%
OBIO icon
5
Orchestra BioMed
OBIO
$238M
$238M $3.98 0.25%
MGNX icon
6
MacroGenics
MGNX
$235M
$235M $3.69 2.38%
RNAC icon
7
Cartesian Therapeutics
RNAC
$229M
$229M $7.80 0.91%
CAPR icon
8
Capricor Therapeutics
CAPR
$223M
$223M $3.85 8.11%
ACIU icon
9
AC Immune
ACIU
$223M
$223M $2.19 7.59%
CNXU
10
Conexeu Sciences Inc
CNXU
$222M
$222M $8.31 5.89%
CGEN icon
11
Compugen
CGEN
$222M
$222M $2.35 0.43%
TARA icon
12
Protara Therapeutics
TARA
$220M
$220M $3.92 2.73%
CHRS icon
13
Coherus Oncology
CHRS
$217M
$217M $1.41 4.08%
MSLE
14
Satellos Bioscience
MSLE
$208M
$208M $9.99 3.42%
KROS icon
15
Keros Therapeutics
KROS
$199M
$199M $10.07 1.47%
GLSI icon
16
Greenwich LifeSciences
GLSI
$198M
$198M $13.50 3.71%
GALT icon
17
Galectin Therapeutics
GALT
$196M
$196M $2.97 8.05%
RNA
18
Atrium Therapeutics
RNA
$194M
$194M $11.35 0.96%
ANTX icon
19
AN2 Therapeutics
ANTX
$193M
$193M $5.35 0.38%
WHWK
20
Whitehawk Therapeutics
WHWK
$190M
$190M $3.85 0%
IMUX icon
21
Immunic
IMUX
$190M
$190M $13.97 0.14%
NERV icon
22
Minerva Neurosciences
NERV
$185M
$185M $3.98 1%
NBP
23
NovaBridge Biosciences American Depositary Shares
NBP
$185M
$185M $1.60 2.44%
VYGR icon
24
Voyager Therapeutics
VYGR
$183M
$183M $3.03 3.19%
OTLK icon
25
Outlook Therapeutics
OTLK
$183M
$183M $0.9766 6.1%
1
2 3 4 5

Micro Cap Biotechnology Stocks at a Glance

Biotechnology companies research and develop novel drugs and therapies, often with no products yet on the market. Clinical-trial readouts and regulatory decisions drive binary stock moves, making pipeline breadth, cash runway, and partnership deals the key variables.

There are 281 micro cap Biotechnology stocks — companies in the Biotechnology industry with a market cap under $250M — worth a combined $18.7B.

The largest by market cap are Turn Therapeutics (TTRX) at $249M, Veraxa Biotech AG (VRXA) at $249M and Adagene (ADAG) at $248M.

Among institutional investors, Atrium Therapeutics (RNA) drew the most net new fund positions in Q1 2026: 162 funds opened new positions.

Market caps and prices updated daily; fund activity based on aggregated SEC 13F filings for Q1 2026.